EMA’s PRAC finds no link between mRNA Covid-19 vaccines and menstruation

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has found no link between messenger ribonucleic acid (mRNA) Covid-19 vaccines and the absence of menstruation (amenorrhea). The development comes after the committee analysed all the available findings, including cases reported during clinical trials, those reported spontaneously in Eudravigilance and data from the literature. Data also comprise the literature and cases of amenorrhea reported to EudraVigilance following dosing with the Covid-19 vaccines of Pfizer-BioNTech and Moderna, Comirnaty and Spikevax, respectively.